Full menu


Tae Han Kim, Ph.D. President & CEO Profile

Samsung BioLogics entered the biopharmaceutical industry during a time of significant changes. The global availability and capacity for biologics manufacturing are decreasing and new innovative types of medicines are being developed to help millions suffering from devastating diseases.

Our vision is to become the most competitive CMO and offer a significant increase in available capacity. This will allow our client partners to provide valuable biological medicines to their patients both cost-effectively and on time. To realize this vision, we have built a unique continual processing platform for the manufacturing of biopharmaceutical products with quality and executional excellence in compliance with the U.S. FDA, EMA, PMDA, and MFDS regulations.

We pride ourselves in delivering superior customer satisfaction through better quality, superior service, and compliance. Based on Samsung’s principles of Quality First and a track record for excellence in plant design, construction, operations and execution, our competitiveness surpasses our rivals without sacrificing quality, regulatory compliance, or our business ethics. While continuing to implement current industry best practices, we strive together with our clients to set higher standards for biopharmaceutical manufacturing.

Our operations are designed to fully comply with international regulatory and cGMP requirements and are overseen by our Quality Division. Our advanced facilities are able to manufacture biological products from early development through commercial supply stages. Furthermore, our experienced people provide expertise in cell culture, purification, analytical testing, fill & finish, and packaging. Our diverse capabilities, manufacturing scale, and flexibility represent a truly integrated one-stop service that meets all our clients’ needs.

We will continue expanding our facilities and capabilities to meet growing market demand. As a global company, we pledge to continue Samsung’s legacy of excellence by combining our business, manufacturing, and engineering expertise, to bring innovation and progress to today’s biopharmaceutical industry.

Sincerely yours,

Tae Han Kim President & CEO, Samsung BioLogics